Archive for the ‘Regenerative Medicine’ Category

SCMOM 2012_UC Davis - Wheelock
UC Davis is playing a leading role in regenerative medicine, with nearly 150 scientists working on a variety of stem cell-related research projects at campus locations in both Davis and Sacramento. The UC Davis Institute for Regenerative Cures, a facility supported by the California Institute for Regenerative Medicine (CIRM), opened in 2010 on the Sacramento campus. This $62 million facility is the university #39;s hub for stem cell science. It includes Northern California #39;s largest academic Good Manufacturing Practice laboratory, with state-of-the-art equipment and manufacturing rooms for cellular and gene therapies. UC Davis also has a Translational Human Embryonic Stem Cell Shared Research Facility in Davis and a collaborative partnership with the Institute for Pediatric Regenerative Medicine at Shriners Hospital for Children Northern California. All of the programs and facilities complement the university #39;s Clinical and Translational Science Center, and focus on turning stem cells into cures. http://www.ucdmc.ucdavis.edu/stemcellresearch Presenter: Vicki L. Wheelock, MD, Clinical Professor, Neurology, Director, HDSA Center of Excellence, Principle Investigator, CIRM Grant DR2A-05415, UC Davis Health SystemFrom:AllianceRegenMedViews:1 0ratingsTime:12:18More inScience Technology

Read more from the original source:
SCMOM 2012_UC Davis - Wheelock - Video

SCMOM 2012_Cedars-Sinai Regenerative Medicine Institute
The Cedars-Sinai Regenerative Medicine Institute (RMI) brings together research faculty and clinicians to provide a true "bench to bedside" organization. We have five major programs of research: (i) Brain, (ii) Eye, (iii) Pancreas and Liver, (iv) Blood and (v) Skeletal. Working within each of these programs benefits from our core facilities with a focus on generating induced pluripotent stem cells from adult human skin samples and optimizing differentiation into various tissues of the human body of interest to the six programs. The pluripotent cells are used to both increase our understanding of human diseases through modeling, and provide a foundation for pre-clinical studies aimed at establishing and validating cellular therapeutic approaches to human illness. http://www.cedars-sinai.edu/Research-and-Education/Institutes/Regenerative-Medicine-Institute Presenter: Clive Svendsen, Ph.D., Director, Cedars-Sinai Regenerative Medicine InstituteFrom:AllianceRegenMedViews:1 0ratingsTime:13:27More inScience Technology

Read more:
SCMOM 2012_Cedars-Sinai Regenerative Medicine Institute - Video

SCMOM 2012_CIRM
Morrie Ruffin, Managing Director, Alliance for Regenerative Medicine Jonathan Thomas, Ph.D., JD, Chair, Governing Board, CIRM (Independent Citizens Oversight Committee)From:AllianceRegenMedViews:2 1ratingsTime:22:41More inScience Technology

Read this article:
SCMOM 2012_CIRM - Video

SCMOM 2012_NeoStem
NeoStem, Inc. is an emerging technology leader in the fast-developing cell therapy market. Its business strategy combines a state-of-the-art contract development and manufacturing subsidiary, Progenitor Cell Therapy, LLC, with a medically important cell therapy product development program. NeoStem #39;s most clinically advanced therapeutic, AMR-001, is being developed at its Amorcyte subsidiary, which is enrolling patients in a Phase 2 trial for preservation of heart function after a heart attack. Athelos Corporation, also a NeoStem subsidiary, is in early stage clinical exploration of a T-cell therapy for autoimmune conditions. Pre-clinical assets include our VSELTM Technology platform and our mesenchymal stem cell product candidate for regenerative medicine. http://www.neostem.com Presenter: Jonathan Sackner-Bernstein, NeoStem, Inc.From:AllianceRegenMedViews:4 1ratingsTime:14:54More inScience Technology

Read more from the original source:
SCMOM 2012_NeoStem - Video

SCMOM 2012_Nanofiber Solutions
Nanofiber Solutions, LLC is a medical device manufacturer of three-dimensional (3-D) scaffolds and cell culture products that advance biological sciences. Our platform technology provides synthetic structures that mimic physical structures found in the human body, specifically the extracellular matrix (ECM). By mimicking the ECM, our scaffolds increase cell acceptance and allow for the development of products that significantly aid basic research, improve commercial drug and therapeutic development, and serve as a platform for artificial implants. Our scaffolds currently support three major areas of medicine; tissue engineering, regenerative medicine and basic research. http://www.nanofibersolutions.com Presenter: Ross Kayuha, CEO, Nanofiber SolutionsFrom:AllianceRegenMedViews:3 1ratingsTime:09:22More inScience Technology

Link:
SCMOM 2012_Nanofiber Solutions - Video

SCMOM 2012_Regenerative Patch Technologies
Regenerative Patch Technologies was formed to advance development of a composite RPE cell-membrane technology currently supported by a disease team award to the University of Southern California, the University of California, Santa Barbara, and the California Institute of Technology from the California Institute of Regenerative Medicine. The technology utilizes polarized RPE cells derived from human embryonic stem cells together with an ultrathin biocompatible parylene membrane as a replacement for the defective Bruch #39;s membrane RPE cell complex often observed in patients with the atrophic form of age related macular degeneration. The project is progressing through preclinical studies to enable IND filing in 2014. http://www.regenerativepatch.com Presenter: Jane Lebkowski, President and CSO, Regenerative Patch TechnologiesFrom:AllianceRegenMedViews:11 1ratingsTime:15:22More inScience Technology

Go here to see the original:
SCMOM 2012_Regenerative Patch Technologies - Video

SCMOM 2012_Case Presentation: The Pervasis Acquisition
Dean Tozer, Vice President, Corporate Development, Shire Regenerative MedicineFrom:AllianceRegenMedViews:2 1ratingsTime:33:11More inScience Technology

View post:
SCMOM 2012_Case Presentation: The Pervasis Acquisition - Video

SCMOM 2012_Regen BioPharma, Inc.
The Regen BioPharma business model is to take multiple stem cell therapeutics to and through the human "safety and signal of efficacy" stage (Phase I/II clinical trials). The approach is a highly focused analysis of issued patents in regenerative medicine, identification and acquisition of undervalued assets that have demonstrated proof of concept, and forming companies around these assets. Having assembled a core infrastructure specialized in obtaining regulatory approval and executing clinical trials in cell therapy, we aim to act as a "superincubator" that within 18 - 24 months grows technologies from laboratory to an asset ready for spin-off or sale to feed the pipeline of Big Pharma. http://www.regenbiopharma.com Presenter: J. Christopher Mizer, President, Regen BioPharma, Inc.From:AllianceRegenMedViews:4 1ratingsTime:09:13More inScience Technology

Originally posted here:
SCMOM 2012_Regen BioPharma, Inc. - Video

SCMOM 2012_The Clinical Outlook for Regenerative Medicine
As many regenerative medicine and cell therapy products move into clinical trials, a clearer understanding of how these products will perform clinically is critical for achieving regulatory approval and ultimately, for commercialization. This session will discuss the major clinical events expected to drive the regenerative medicine sector over the next two years, as well as address some of the key issues facing these products as they approach the marketplace. Moderator: Greg Lucier, MBA, Chairman and CEO, Life Technologies Panelists: Jay Siegel, MD, Chief Biotechnology Officer and Head, Global Pharmaceutical Regulatory Affairs, Janssen Pharmaceutical Companies of Johnson Johnson Paul Simmons, Ph.D., Executive Vice President, Corporate Research and Product Development, Mesoblast Limited Matthias Steger, Ph.D., MBA, Global Head Research and Technology Partnering, Roche Ltd. Dean Tozer, Vice President, Corporate Development, Shire Regenerative MedicineFrom:AllianceRegenMedViews:5 1ratingsTime:01:16:22More inScience Technology

See the article here:
SCMOM 2012_The Clinical Outlook for Regenerative Medicine - Video

The Cure: A Documentary on Regenerative Medicine (Part 1)
Filmmaker David Alvarado tells the remarkable, behind-the-scenes story on the founding of the Silicon Valley Institute of Regenerative Medicine. Through a public/private partnership with Santa Clara Valley Medical Center, Stanford University, the County of Santa Clara, the Palo Alto VA and others, the Institute hopes to facilitate major breakthroughs in the treatment of spinal cord and other injuries using stem cells.From:VMCFoundationViews:2 0ratingsTime:07:07More inScience Technology

Read the original post:
The Cure: A Documentary on Regenerative Medicine (Part 1) - Video

RegenKit - Regenerative Medicine
Learn more about the benefits of Regenerative Medicine.From:towncountryhospitalViews:2 0ratingsTime:02:18More inEducation

Originally posted here:
RegenKit - Regenerative Medicine - Video

MargaritaSays: Anti-Aging with Aubrey De Grey
Aubrey David Nicholas Jasper de Grey (/d #601; #712; #609;re #618;/; born 20 April 1963) is an English author and theoretician in the field of gerontology, and the Chief Science Officer of the SENS Foundation. He is editor-in-chief of the academic journal Rejuvenation Research, author of The Mitochondrial Free Radical Theory of Aging (1999) and co-author of Ending Aging (2007). He is perhaps best known for his view[neutrality is disputed] that human beings could, in theory, live to lifespans far in excess of that which any authenticated cases have lived to today. De Grey #39;s research focuses on whether regenerative medicine can thwart the aging process. He works on the development of what he calls "Strategies for Engineered Negligible Senescence" (SENS), a tissue-repair strategy intended to rejuvenate the human body and allow negligible senescence. To this end, he has identified seven types of molecular and cellular damage caused by essential metabolic processes. SENS is a proposed panel of therapies designed to repair this damage.[2] The "pro-aging trance" is a term coined by Grey to describe "the impulsion to leap to embarrassingly unjustified conclusions in order to put the horror of aging out of one #39;s mind".[17] According to de Grey, the pro-aging trance or "pro-aging edifice"[18] is a psychological strategy which people use in order to cope with aging, and which is rooted in the belief that aging is immutable and unavoidable. De Grey refers, in this regard, to the general public #39;s ...From:MargaritaShamrakovViews:2 1ratingsTime:10:13More inPeople Blogs

View post:
MargaritaSays: Anti-Aging with Aubrey De Grey - Video

"Regenerative Medicine: 2012"
Dr. Anthony Atala, the director of the Wake Forest Institute for Regenerative Medicine, talks about his latest achievements in growing new human cells, tissues, and organs.From:NewYorkerDotComViews:9 1ratingsTime:19:55More inEntertainment

See original here:
"Regenerative Medicine: 2012" - Video

4th Annual SLU Hair Transplant Course: Platelet Rich Plasma (PRP) Acell
http://www.hairtx.com Dallas Hair Transplant Surgeon, Dr. Sam Lam, as Course Director of the 4th Annual St. Louis University Hair Transplant 360 Course, overviews how he uses regenerative medicine techniques with his hair transplants and independent of his hair transplants, specifically PRP (Platelet Rich Plasma) and Acell. Key words hair transplant, dallas, texas, hair restoration, course, dr. sam lam, regenerative medicine, prp, platelet rich plasma, acell, porcine bladderFrom:samlammdViews:2 0ratingsTime:13:22More inScience Technology

See the rest here:
4th Annual SLU Hair Transplant Course: Platelet Rich Plasma (PRP)

Doctors Treat Dog Paralysis Using Nose Cell Transplant
In an amazing report, doctors treat dog paralysis with nose cell transplant. Scientists at Cambridge University #39;s Veterinary School working with the Medical Research Council #39;s Regenerative Medicine Centre have partially treated paralysis in dogs by injecting them with transplanted cells. All of the dogs had spinal injuries that left their back legs paralyzed. The cells that the scientists used were taken from the olfactory ensheathing cells in the lining of the dog #39;s noses. 34 dogs took part in the trial, with 23 of them having transplant cells injected into their paralyzed legs. The rest were used as a control group and were given a neutral fluid injection. None of the dogs in the control group gained any use of their legs, but many of the dogs that were given the transplant cells had improved movement capabilities. Co-author of the study, Professor Robin Franklin told the BBC: #39;Our findings are extremely exciting because they show for the first time that transplanting these types of cell into a severely damaged spinal cord can bring about significant improvement." This is the first study that shows cells taken from the nose can be used to treat severe spinal chord damage.From:GeoBeatsNewsViews:1 0ratingsTime:01:05More inNews Politics

Follow this link:
Doctors Treat Dog Paralysis Using Nose Cell Transplant - Video

Talking About Art Young Adults Studying About Regenerative Medicine
This art will be for sale. The art is inspired by the possible prospect of radical life extension technologies and regenerative medicine. Encouraging young adults to studying these fields in college/university is also discussed here. idea-archive.net http Please subscribe to this channel, share this video with others, visit my websites and watch my other videos. Thanks for watching. Also, please checkout my Etsy store. http://www.etsy.com Comments are welcomed and encouraged. However, if they contain rudeness, disrespect or swear words, then they will likely be removed.From:APerfectUniverseViews:0 1ratingsTime:07:44More inEntertainment

Read the original here:
Talking About Art

Nose cell transplant enables paralysed dogs to walk
cientists have reversed paralysis in dogs after injecting them with cells grown from the lining of their nose. The pets had all suffered spinal injuries which prevented them from using their back legs. The Cambridge University team is cautiously optimistic the technique could eventually have a role in the treatment of human patients. The study is the first to test the transplant in "real-life" injuries rather than laboratory animals. Treadmill Of 34 pet dogs on the proof of concept trial, 23 had the cells transplanted into the injury site - the rest were injected with a neutral fluid. Many of the dogs that received the transplant showed considerable improvement and were able to walk on a treadmill with the support of a harness. None of the control group regained use of its back legs. The research was a collaboration between the MRC #39;s Regenerative Medicine Centre and Cambridge University #39;s Veterinary School. Professor Robin Franklin, a regeneration biologist at the Wellcome Trust-MRC Stem Cell Institute and report co-author, said: #39;Our findings are extremely exciting because they show for the first time that transplanting these types of cell into a severely damaged spinal cord can bring about significant improvement. "We #39;re confident that the technique might be able to restore at least a small amount of movement in human patients with spinal cord injuries but that #39;s a long way from saying they might be able to regain all lost function. #39; Prof Franklin said the procedure ...From:NEWSHD2012Views:11300 51ratingsTime:00:21More inPets Animals

Continue reading here:
Nose cell transplant enables paralysed dogs to walk - Video

cord blood donation | How Cord Blood Stem Cell Can Bring Hope to People Suffering From Life
http://www.cordbloodrecommendation.com A large number of people die waiting for a transplant due to this reason. Well, there are still debates on this issue. Human umbilical cord blood cells are very rich in stem cells and progenitor cells which make them the perfect place to take cells from and then store them in a cord blood bank or a stem cells bank. There is also another option given by non-profit cord blood banks, of free programs through which one can store umbilical cord blood stem cell samples. Others choose to donate the blood to a public bank for the public good. Given the progress that stem cell research and regenerative medicine have attained at present, and the promise that they show for the future, stem cell transplants may one day provide a cure for type 1 diabetes, heart disease, and brain injury, among other potentially life threatening and debilitating illnesses and conditions with inadequate treatment options today. One study in particular by Wagner, et al. ""Settling on a name for your newborn is definitely something all parents spend time doing, but one decision that is rarely thought of or overlooked is saving your newborn #39;s cord blood. However, you can choose to make a once-in-a-lifetime decision to collect and store your baby #39;s cord blood stem cells after the birth of your newborn baby. It is able to kill either normal or cancer-producing blood cells of the bone marrow. Your child #39;s umbilical cord blood contains special cells known as stem cells. Thus, it ...From:Alexander santafeViews:0 0ratingsTime:01:31More inScience Technology

See the article here:
cord blood donation | How Cord Blood Stem Cell Can Bring Hope to People Suffering From Life - Video

stem cell | Advantages Of Cord Blood Banking
http://www.cordbloodrecommendation.com Programs Available to Store the Blood There are a small number of programs in the US currently (December 2011) that save cord blood. Before you decide on a specific cord blood bank, contact the AABB to determine if the private blood bank is accredited or if it has any complaints lodged against the facility by other patrons. It really should be observed that the technique has a high risk of complication. Keep in mind that cord blood storage acts as an insurance policy for your family, so consider any other factors before immediately determining not to store your child #39;s cord blood simply because of price. One more cord blood donation might just be enough to save another life. Given the progress that stem cell research and regenerative medicine have attained at present, and the promise that they show for the future, stem cell transplants may one day provide a cure for type 1 diabetes, heart disease, and brain injury, among other potentially life threatening and debilitating illnesses and conditions with inadequate treatment options today. In addition, you have to decide well in advance of the due date because once you lose the precious blood, you cannot regain it. The patient no longer needs to wait for a donor; he can be his own donor if his cord blood had been preserved after his birth. The ultimate decision to bank cord stem cells or not is a personal decision as to what is deemed appropriate for that particular family, but in making that ...From:loshoteles enmedellinViews:0 0ratingsTime:01:31More inScience Technology

Read the original here:
stem cell | Advantages Of Cord Blood Banking - Video

cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy
http://www.cordbloodrecommendation.com These diseases include blood related, genetic and neurotic disorders. ""Banking the umbilical cord blood when your baby is born is a relatively new idea, the first operation using it to help cure a child with Leukemia was only done a little over 10 years ago. After processing of cells, comes the next procedure of cord blood preservation. There is also another option given by non-profit cord blood banks, of free programs through which one can store umbilical cord blood stem cell samples. A man can change his god-gifted features wishfully with the help of science. Given the progress that stem cell research and regenerative medicine have attained at present, and the promise that they show for the future, stem cell transplants may one day provide a cure for type 1 diabetes, heart disease, and brain injury, among other potentially life threatening and debilitating illnesses and conditions with inadequate treatment options today. With people not fully understanding how important stem cells could be for us, everybody agrees that more research need to be done in order to help understand all that. If there is any complication during delivery, the entire idea is abandoned. It is always wise to preserve this waste blood of the baby which is otherwise thrown away. You are injecting the patient with those same cells that created him!This can be done with the bone marrow transplants tooYes, stem cells are found in bone marrows too. It is a simple and ...From:luisantafeViews:0 0ratingsTime:01:31More inScience Technology

Read the original:
cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy - Video

A dog called Jasper during trial to show spinal cord regeneration
In a unique collaboration between the University #39;s Veterinary School and MRC #39;s Regenerative Medicine Centre, scientists used a unique type of cell to regenerate the damaged part of the dogs #39; spines. The researchers are cautiously optimistic that the work could have a future role in the treatment of human patients with similar injuries if used alongside other treatments. For more information, go to http://www.cam.ac.ukFrom:CambridgeUniversityViews:8805 46ratingsTime:00:46More inEducation

Read the rest here:
A dog called Jasper during trial to show spinal cord regeneration - Video

Call for Nominations: "Stem Cell Person of the Year"
UC Davis stem cell scientist Paul Knoepfler is seeking nominees for the 2012 "Stem Cell Person of the Year." He created the new award to recognize an individual who has made an outstanding difference in the field of stem cell-based cellular and regenerative medicine. Nominees can be scientists, patient advocates, individuals from industry or just about anyone who has made the stem cell field better. The award includes a $1000 cash prize.From:UCDavisHealthViews:60 2ratingsTime:01:48More inScience Technology

Read more from the original source:
Call for Nominations: "Stem Cell Person of the Year" - Video

Review Of An Academic Paper Related To Regenerative Medicine
sens.org (The paper that I am reviewing should be second link down within the bibliography section.) The bibliography of it is: Bussel II, Stupple A, Moody KJ, Lefkowitz DM. Call to action: medical students for regenerative medicine. Rejuvenation Res. 2010 Feb;13(1):1-2. PubMed: 20230272. Support abolishing aging. Support regenerative medicine. Considering studying it. Especially young adults should. idea-archive.net http Please subscribe to this channel, share this video with others, visit my websites and watch my other videos. Thanks for watching. Also, please checkout my Etsy store. http://www.etsy.com Comments are welcomed and encouraged. However, if they contain rudeness, disrespect or swear words, then they will likely be deleted.From:APerfectUniverseViews:14 2ratingsTime:04:43More inPeople Blogs

Read the rest here:
Review Of An Academic Paper Related To Regenerative Medicine - Video

Byrd Aesthetic and Anti-Aging Center CoolSculpting Commerical
http://www.byrdaesthetic.com CoolSculpting trade; is cleared by the FDA for the non-invasive reduction of fat. This procedure is a clinically proven method for the selective reduction of body fat. The unwanted fat cells are gently cooled inducing a natural, controlled elimination. Results are permanent. Dr. Marcia Byrd of the Byrd Aesthetic and Anti-Aging Center is located in Atlanta, Georgia. She is board-certified by the American Board of Laser Surgery and the American Board of Anti-Aging and Regenerative Medicine. For more information about CoolSculpting trade; and losing unwanted fat, call Dr. Byrd #39;s office toll free at 1.866.671.5633.From:DefinitiveMedicalViews:1 0ratingsTime:00:31More inScience Technology

More here:
Byrd Aesthetic and Anti-Aging Center CoolSculpting Commerical - Video

HM Harvard Apparatus
A motion graphics video for the new regenerative medicine concept from Harvard Apparatus.From:BlueWave BuzzViews:1 0ratingsTime:01:10More inNews Politics

Read more:
HM Harvard Apparatus - Video